Coloplast A/S (CLPBF)
68.32
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Coloplast Shareholders Equity (Quarterly) : 2.045B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.045B |
| March 31, 2026 | 1.980B |
| December 31, 2025 | 2.171B |
| September 30, 2025 | 2.538B |
| June 30, 2025 | 2.588B |
| March 31, 2025 | 2.453B |
| December 31, 2024 | 2.147B |
| September 30, 2024 | 2.686B |
| June 30, 2024 | 2.375B |
| March 31, 2024 | 2.346B |
| December 31, 2023 | 2.241B |
| September 30, 2023 | 2.456B |
| June 30, 2023 | 950.94M |
| March 31, 2023 | 1.026B |
| December 31, 2022 | 847.46M |
| September 30, 2022 | 1.093B |
| June 30, 2022 | 1.023B |
| March 31, 2022 | 1.088B |
| December 31, 2021 | 981.46M |
| September 30, 2021 | 1.273B |
| June 30, 2021 | 1.105B |
| March 31, 2021 | 1.096B |
| December 31, 2020 | 948.47M |
| September 30, 2020 | 1.167B |
| June 30, 2020 | 958.72M |
| Date | Value |
|---|---|
| March 31, 2020 | 968.42M |
| December 31, 2019 | 818.84M |
| September 30, 2019 | 1.009B |
| June 30, 2019 | 906.16M |
| March 31, 2019 | 928.46M |
| December 31, 2018 | 795.35M |
| September 30, 2018 | 999.63M |
| June 30, 2018 | 815.17M |
| March 31, 2018 | 886.99M |
| December 31, 2017 | 759.79M |
| September 30, 2017 | 945.54M |
| June 30, 2017 | 760.57M |
| March 31, 2017 | 728.34M |
| December 31, 2016 | 597.77M |
| September 30, 2016 | 764.87M |
| June 30, 2016 | 671.81M |
| March 31, 2016 | 752.99M |
| December 31, 2015 | 586.04M |
| September 30, 2015 | 704.15M |
| June 30, 2015 | 865.23M |
| March 31, 2015 | 930.56M |
| December 31, 2014 | 876.70M |
| September 30, 2014 | 1.066B |
| June 30, 2014 | 995.92M |
| March 31, 2014 | 1.079B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ambu A/S | 943.41M |
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.179B |
| Total Liabilities (Quarterly) | 5.135B |
| Debt to Equity Ratio | 1.781 |
| Current Ratio | 1.561 |
| Net Debt Paydown Yield | -0.20% |